Provided by Tiger Trade Technology Pte. Ltd.

Incyte

123.60
+0.38000.31%
Volume:449.78K
Turnover:55.59M
Market Cap:25.05B
PE:15.75
High:125.14
Open:124.61
Low:122.50
Close:123.22
52wk High:132.60
52wk Low:81.09
Shares:202.70M
Float Shares:169.82M
Volume Ratio:0.68
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.85
EPS(LYR):6.41
ROE:30.67%
ROA:16.83%
PB:3.95
PE(LYR):19.28

Loading ...

Incyte Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 01

Incyte Price Target Maintained with a $140.00/share by HC Wainwright & Co.

Dow Jones
·
Jun 29

Barclays Keeps Their Buy Rating on Incyte (INCY)

TIPRANKS
·
Jun 29

Weekly Winners | Bio-Techne Soars 23%; AbbVie Surges 17%; United Airlines Jumps 15%; Corning, Merck Gain 13%

Tiger Newspress
·
Jun 28

Accenture, Estée Lauder, Luckin, Incyte, BILL Trending

TIPRANKS
·
Jun 27

Incyte Corp. Stock Rises 5.8%, Outperforms Peers

Dow Jones
·
Jun 27

Incyte is Maintained at Neutral by UBS

Dow Jones
·
Jun 27

Incyte Winds Down Itacitinib Rollover Study: What Investors Should Know

TIPRANKS
·
Jun 27

Movement Alert|Incyte Rises 5.84% in Regular Trading, Opzelura Receives Positive EU CHMP Opinion for Atopic Dermatitis

Market Focus
·
Jun 27

Incyte Shares Rise 5.2% After Co Announces Positive EU Regulatory Opinion for Opzelura Skin Disease Treatment

THOMSON REUTERS
·
Jun 26

Incyte to Present Phase 1/2 Vga039 Data in Von Willebrand Disease at ISTH Congress

Reuters
·
Jun 26

Incyte announces positive CHMP opinion of Opzelura Cream

TIPRANKS
·
Jun 26

Incyte Says EMA Panel Backs EU Approval of Opzelura Cream for Moderate Atopic Dermatitis in Adults

Reuters
·
Jun 26

Incyte Announces Positive Chmp Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis

THOMSON REUTERS
·
Jun 26

Incyte (INCY) Lands Fresh Clinical Wins, Is It Fully Valued?

Simply Wall St.
·
Jun 26

UBS Adjusts Price Target on Incyte to $113 From $103

MT Newswires Live
·
Jun 25

Incyte Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

S&P 500 Futures Rise in Premarket Trading; Dick's Sporting Goods, Zimmer Biomet Holdings Lag

Dow Jones
·
Jun 24

Incyte Price Target Maintained with a $140.00/share by HC Wainwright & Co.

Dow Jones
·
Jun 24

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Verastem (VSTM) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jun 24